Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
US Stocks

ISRG Intuitive Surgical NASDAQ pre-market $482.76 18 Mar: AI robotics outlook

March 18, 2026
5 min read
Share with:

We open pre-market with ISRG stock at $482.76 on 18 Mar 2026. Intuitive Surgical, Inc. (ISRG) on NASDAQ remains a focal point for AI-driven robotics investors. The company reported strong top-line momentum and beat January quarter estimates. We review fundamentals, valuation, technicals and how AI and automation trends shape the ISRG outlook for United States investors.

ISRG stock: pre-market snapshot and price action

ISRG opened pre-market at $482.76 on NASDAQ with a prior close of $483.46. Intraday range shows a low of $482.19 and high of $494.43. Volume is 1,042,355 versus average volume 1,907,022, indicating below-average trading so far. The one-year range is $425.00 to $603.88, and market cap stands near $171.44B USD. These figures connect directly to near-term momentum and analyst price targets.

Sponsored

Earnings and fundamentals that matter for ISRG

Intuitive Surgical reported $2.53 EPS in the January quarter, beating consensus. Trailing EPS is 7.89 and trailing P/E is 61.19. Revenue grew 18.8% year-over-year in the last quarter. Key margins remain strong with a net margin near 28.38%. Cash per share is $16.72 and free cash flow per share is 7.02. These metrics underline durable profitability but also a premium valuation.

Valuation, ownership and risk factors for ISRG

ISRG trades at elevated multiples: price-to-sales around 17.07 and price-to-free-cash-flow near 69.11. Institutional investors own 83.64% of shares. Recent insider selling totaled 32,943 shares in the last 90 days. Cybersecurity reports and concentrated institutional ownership are two risk vectors. Analysts show a consensus of Moderate Buy with average price targets near $615.86, highlighting divergent views on valuation versus growth.

AI and robotics growth thesis for Intuitive Surgical

We view ISRG as an AI stocks play through robotics automation and procedure intelligence. The da Vinci platform plus Ion diagnostic expansion drive instrument and software repeat revenue. Research and development runs about 13.03% of revenue, supporting advanced software and AI features. Hospitals’ shift to minimally invasive, data-driven procedures supports durable instrument attach rates and services revenue for the NASDAQ-listed company in the United States market.

Technical outlook and trading setup for ISRG stock

Momentum indicators show mixed signals. RSI sits at 42.05, below neutral. MACD is negative with histogram small, implying cooling momentum. The 50-day average is $513.75 and the 200-day average is $510.91, both above current price. Bollinger middle band is $493.93 and ATR is 14.08, suggesting volatility near recent range. Traders should watch a break above $494.43 or below $482.19 for directional conviction.

Meyka AI rates ISRG with a score out of 100 and forecast

Meyka AI rates ISRG with a score out of 100: 79.75 (B+) — BUY. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a quarterly target of $485.77 and a one-year target of $585.45. Compared with the current price of $482.76, the one-year model implies an upside of 21.27%. Forecasts are model-based projections and not guarantees. For additional company detail see the official site Intuitive Surgical and recent reporting at MarketBeat report. Meyka AI is the AI-powered market analysis platform behind this grade.

Final Thoughts

Key takeaways: ISRG stock trades at $482.76 pre-market on NASDAQ with strong earnings momentum but premium multiples. Fundamentals show high margins, solid cash flow and a trailing P/E of 61.19. The AI and robotics secular trend supports product attach rates and recurring revenue, while cybersecurity reports and insider sales are near-term risks. Meyka AI’s forecast model projects a one-year target of $585.45, implying about 21.27% upside from the current price. Investors should weigh premium valuation against AI-driven growth potential and monitor upcoming earnings and any operational disclosures. Forecasts are model-based projections and are not guarantees.

FAQs

What is the current price and market status of ISRG stock?

ISRG stock is at $482.76 pre-market on 18 Mar 2026. Volume is 1,042,355 with an average volume of 1,907,022. The one-year range is $425.00–$603.88 and market cap is about $171.44B USD.

How does Intuitive Surgical’s valuation compare to peers?

Intuitive trades at premium multiples: P/E about 61.19, P/S roughly 17.07, and P/FCF near 69.11. These ratios reflect strong margins and growth expectations versus typical medical instrument peers.

What does Meyka AI forecast for ISRG stock?

Meyka AI’s forecast model projects a one-year target of $585.45, implying 21.27% upside from the current $482.76 price. Forecasts are model-based and not guarantees.

What are the main risks for Intuitive Surgical investors?

Key risks include high valuation, recent insider selling, reported cybersecurity incidents, and reimbursement or regulatory shifts. Concentrated institutional ownership can amplify price moves.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
~15% average open rate and growing
Trusted by 10,000+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)